Glimbetic-MV 2/0.2 Tablet
Marketer
Kepran Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (0.2mg)
Overview Glimbetic-MV 2/0.2 Tablet
Combiflex-DM 2/0.2 is a dual-action tablet formulated to manage blood glucose. In conjunction with diet and exercise, it enhances glycemic control in adult type 2 diabetics. This medication promotes efficient insulin use, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and frequency. Take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose can cause hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption as it may exacerbate side effects.
Uses of Glimbetic-MV 2/0.2 Tablet
Managing type 2 diabetes
Major Benefits of Glimbetic-MV 2/0.2 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimbetic-MV 2/0.2 Tablet with a meal.
Common Side effects of Glimbetic-MV 2/0.2 Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimbetic-MV 2/0.2 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Glimbetic-MV 2/0.2 Tablet with a meal.
How Glimbetic-MV 2/0.2 Tablet works:
Glimbetic-MV 2/0.2 tablets contain a triple-action formulation of glimepiride, metformin, and pioglitazone to manage blood sugar levels. These medications employ distinct methods of action, offering superior glycemic control when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimbetic-MV 2/0.2 Tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Glimbetic-MV 2/0.2 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimbetic-MV 2/0.2 Tablet while breastfeeding is likely inadvisable. Scant available evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such conditions arise.
KidneyCAUTION
Patients with kidney impairment should use Glimbetic-MV 2/0.2 Tablet cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates its use. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimbetic-MV 2/0.2 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimbetic-MV 2/0.2 Tablet is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimbetic-MV 2/0.2 Tablet :
Should you forget to take your Glimbetic-MV 2/0.2 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimbetic-MV 2/0.2 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |




